Jamy O - Search Results

1

Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia.

Jamy O, Diebold K, Davis K, Bachiashvili K, Rangaraju S, Vachhani P, Godby KN, Salzman D, Bhatia R. Jamy O, et al. Bone Marrow Transplant. 2023 Jul;58(7):823-825. doi: 10.1038/s41409-023-01977-7. Epub 2023 Apr 3. Bone Marrow Transplant. 2023. PMID: 37012416 No abstract available.

2

Clinical applications of the pedicled anterolateral thigh flap in penile reconstruction.

Rashid M, Aslam A, Malik S, Tamimy MS, Ehtesham-ul-Haq, Aman S, Jamy O. Rashid M, et al. Among authors: jamy o. J Plast Reconstr Aesthet Surg. 2011 Aug;64(8):1075-81. doi: 10.1016/j.bjps.2011.01.009. Epub 2011 Feb 15. J Plast Reconstr Aesthet Surg. 2011. PMID: 21324765

3

Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine.

Wiedower E, Jamy O, Martin MG. Wiedower E, et al. Among authors: jamy o. Anticancer Res. 2015 Nov;35(11):6287-90. Anticancer Res. 2015. PMID: 26504064

4

Outcomes of fludarabine, high dose cytarabine and granulocyte-colony stimulating factor (FLAG) as re-induction for residual acute myeloid leukemia on day 14 bone marrow.

Jamy O, Bae S, Costa LJ, Erba HP, Papadantonakis N. Jamy O, et al. Leuk Res. 2018 Nov;74:64-67. doi: 10.1016/j.leukres.2018.09.014. Epub 2018 Sep 27. Leuk Res. 2018. PMID: 30300822 Clinical Trial.

5

Risk and outcomes of second malignant neoplasms in chronic myeloid leukemia survivors.

Jamy O, Sarmad R, Costa L. Jamy O, et al. Leuk Res. 2019 Jul;82:1-6. doi: 10.1016/j.leukres.2019.05.004. Epub 2019 May 13. Leuk Res. 2019. PMID: 31108340

6

Survival of chronic myeloid leukemia patients in comparison to the general population in the tyrosine kinase inhibitors era: A US population-based study.

Jamy O, Godby R, Sarmad R, Costa LJ. Jamy O, et al. Am J Hematol. 2021 Jul 1;96(7):E265-E268. doi: 10.1002/ajh.26195. Epub 2021 May 1. Am J Hematol. 2021. PMID: 33864684 Free article. No abstract available.

7

Impact of insurance status on the survival of younger patients diagnosed with acute promyelocytic leukemia in the United States.

Jamy OH, Godby R, Dhir A, Costa LJ, Xavier AC. Jamy OH, et al. Cancer. 2021 Aug 15;127(16):2966-2973. doi: 10.1002/cncr.33593. Epub 2021 Apr 23. Cancer. 2021. PMID: 33891351 Free article.

8

Impact of sociodemographic factors on early mortality in acute promyelocytic leukemia in the United States: A time-trend analysis.

Jamy OH, Dhir A, Costa LJ, Xavier AC. Jamy OH, et al. Cancer. 2022 Jan 15;128(2):292-298. doi: 10.1002/cncr.33914. Epub 2021 Sep 8. Cancer. 2022. PMID: 34495548 Free article.

9

Genomic alterations in neuroendocrine cancers of the ovary.

Yaghmour G, Prouet P, Wiedower E, Jamy OH, Feldman R, Chandler JC, Pandey M, Martin MG. Yaghmour G, et al. J Ovarian Res. 2016 Aug 26;9(1):52. doi: 10.1186/s13048-016-0259-2. J Ovarian Res. 2016. PMID: 27566252 Free PMC article.

10

Acute promyelocytic leukemia during pregnancy: A case report and 10-year institutional review of hematologic malignancies during pregnancy.

Fei F, Faye-Petersen OM, Vachhani P, Jamy O, Reddy VV. Fei F, et al. Among authors: jamy o. Pathol Res Pract. 2019 Dec;215(12):152672. doi: 10.1016/j.prp.2019.152672. Epub 2019 Sep 28. Pathol Res Pract. 2019. PMID: 31587825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters